Under the agreement, Broadlane clients will have access to Integra products for the management of hydrocephalus, backed by Integra sales support. Broadlane clients include more than 1,100 acute-care hospitals and 50,000 non-acute care facilities across the United States.
Read the Integra LifeSciences release about the contract with The Broadlane Group.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
– Integra LifeSciences Receives FDA Clearance for ALIF Device
– Integra LifeSciences Introduces New Retraction System for Minimally Invasive Spine Surgery
